0001493152-18-005018.txt : 20180410 0001493152-18-005018.hdr.sgml : 20180410 20180410204217 ACCESSION NUMBER: 0001493152-18-005018 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171017 FILED AS OF DATE: 20180410 DATE AS OF CHANGE: 20180410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gormally John J CENTRAL INDEX KEY: 0001661118 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 18749040 MAIL ADDRESS: STREET 1: 80 WALSH DRIVE CITY: MAHWAH STATE: NJ ZIP: 07430 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4/A 1 form4a.xml X0306 4/A 2017-10-17 2017-10-24 0 0001321834 Akers Biosciences, Inc. AKER 0001661118 Gormally John J 80 WALSH DRIVE MAHWAH NJ 07430 1 1 0 0 Chief Executive Officer Common Stock 2017-10-17 4 A 0 150000 0.88 A 180000 D On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan. This Form 4/A is being filed to correct a typo in column 3 of table I to reflect that the Common Stock acquired by the reporting party was the result of a grant of Common Stock, not a gift. /s/ John J. Gormally 2018-04-10